Cart summary

You have no items in your shopping cart.

BYL-719

SKU: orb1226776

Description

Alpelisib (BYL-719) is a potent and selective PI3Kα inhibitor with IC50 of 5 nM in a cell-free assay, and minimal effect on PI3Kβ/γ/δ. Phase 2.(In Vitro):Alpelisib (BYL-719) potently inhibits the 2 most common PIK3CA somatic mutations (H1047R, E545K; IC50s~4 nM). Alpelisib potently inhibits Akt phosphorylation in cells transformed with PI3Kα (IC50=74±15 nM) and shows significant reduced inhibitory activity in PI3Kβ or PI3Kδ isoforms transformed cells (≥15-fold compared with PI3Kα).Alpelisib (BYL-719, 0-50 μM; 72 hours) inhibits the cell growth of osteosarcoma cell lines MG63, HOS, POS-1 and MOS-J in a dose-dependent manner.Alpelisib (BYL-719) significantly alters the distribution of cell cycle phases. Alpelisib (BYL-719, 25 μM; 18 hours) induces a cell cycle arrest in the G0/G1 phase of human and murine osteosarcoma cell lines.(In Vivo):Alpelisib (BYL-719) (12.5 mg/kg and 50 mg/kg for C57Bl/6J mice; 50 mg/kg for female Rj:NMRI-nude mice; oral administration; daily) significantly reduces tumor volumes and deposition of ectopic bone matrix.Alpelisib has moderate terminal elimination half-life (t1/2=2.9±0.2 h) for rat (1 mg/kg, iv) .

Images & Validation

Key Properties

CAS Number1217486-61-7
MW441.47
Purity>98% (HPLC)
FormulaC19H22F3N5O2S
SMILESO=C(N1[C@H](C(N)=O)CCC1)NC2=NC(C)=C(C3=CC(C(C)(C)C(F)(F)F)=NC=C3)S2
TargetPI3K
SolubilityEthanol: 2 mg/mL (4.53 mM); DMSO: 88 mg/mL (199.33 mM)

Bioactivity

In Vivo
Animal model: A 5-week-old female Rj: NMRI-nude mice withhuman HOS-MNNG osteosarcoma cells; A 5-week-old male C57Bl/6J mice with mouse MOS-J osteosarcoma cells. Dosage: 12.5 mg/kg and 50 mg/kg for C57Bl/6J mice; 50 mg/kg for female Rj: NMRI-nude mice. Administration: Oral administration; daily; 22 or 29 days for C57Bl/6J mice or Rj: NMRI-nude mice. Result: Significantly reduced tumor volumes and simultaneously reduced tumor growth. Animal model: Female Sprague Dawley rats. Dosage: 1 mg/kg (Pharmacokinetic Analysis). Administration: I. V. Result: t1/2 = 2.9±0.2 hours.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Alpelisib

Similar Products

  • Alpelisib [orb1307105]

    99.73%

    1217486-61-7

    441.47

    C19H22F3N5O2S

    100 mg, 250 mg, 1 g
  • Alpelisib hydrochloride [orb1707687]

    97.64%

    1584128-91-5

    477.93

    C19H23ClF3N5O2S

    50 mg, 100 mg, 25 mg, 5 mg, 2 mg, 10 mg
  • Acalisib [orb1223796]

    >98% (HPLC)

    870281-34-8

    401.3965

    C21H16FN7O

    1 g, 100 mg, 5 mg, 10 mg, 2 mg, 500 mg, 200 mg, 25 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

BYL-719 (orb1226776)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

5 mg
$ 90.00
10 mg
$ 110.00
25 mg
$ 120.00
50 mg
$ 150.00
100 mg
$ 210.00
200 mg
$ 360.00
500 mg
$ 580.00